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Fluorinated surfactantsThe Sonic Hedgehog (Shh) signalling pathway plays an important role both in embryonic development and
in adult stem cell function. Inappropriate regulation of this pathway is often due to dysfunction between two
membrane receptors Patched (Ptc) and Smoothened (Smo), which lead to birth defects, cancer or
neurodegenerative diseases. However, little is known about Ptc, the receptor of the Shh protein, and the way
Ptc regulates Smo, the receptor responsible for the transduction of the signal. To develop structure–function
studies of these receptors, we expressed human Ptc (hPtc) in the yeast Saccharomyces cerevisiae. We
demonstrated that hPtc expressed in a yeast membrane fraction is able to interact with its puriﬁed ligand
Shh, indicating that hPtc is produced in yeast in its native conformational state. Using Surface Plasmon
Resonance technology, we showed that ﬂuorinated surfactants preserve the ability of hPtc to interact with its
ligand after puriﬁcation. This is the ﬁrst report on the heterologous expression and the puriﬁcation of a native
and stable conformation of the human receptor Ptc. This work will allow the scale-up of hPtc production
enabling its biochemical characterization, allowing the development of new therapeutic approaches against
diseases induced by Shh signalling dysfunction.© 2009 Elsevier B.V. All rights reserved.1. Introduction
Hedgehog (Hh) proteins constitute a family of secreted signalling
molecules that govern patterning and morphogenesis in most multi-
cellular organisms [1]. In adult animals, the Hh pathway regulates
tissue stem cells required for organ repair and maintenance [2]. Sonic
Hedgehog (Shh), themost studied of the three vertebrate homologs of
Drosophila Hedgehog, is a secreted protein that acts on target cells to
increase transcription of several genes, including members of theWnt; hSmo, human Smoothened;
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Patched (Ptc). Cellular responses to the secreted morphogen Shh are
mediated by two integral membrane proteins, Ptc and Smoothened
(Smo), which were ﬁrst identiﬁed by genetic screens in Drosophila
[3,4]. In the absence of Shh, Ptc represses the G protein coupled
receptor Smo, which is a positive regulator of the pathway. Once the
Shh protein binds to Ptc, the inhibition of Smo is released and this
allows transduction of the Hh signal [5]. Smo activation then triggers a
series of intracellular events that results in the expression of Hh target
genes through the Ci/Gli family of transcription factors [6]. Dysregu-
lation of the pathway causes birth defects and human cancer [2]. A
recent paper suggests that primary cilia sense Shh and transduce the
signal through Ptc regulation of Smo accumulation within cilia, and
play a critical role in development, carcinogenesis, and stem cell
function [7]. Despite the importance of Hh signalling in mammals,
there are gaps in our understanding of the pathway, such as the
mechanisms allowing Ptc to regulate Smo activation.
Puriﬁcation of Ptc and resolution of its structure are essential to
understand how this protein functions and to identify Ptc ligands
involved in Smo regulation. However, Ptc, like the majority of
medically important mammalian membrane proteins, is present in
tissues at very low concentrations, making overexpression in
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earlier paper, we showed that the human receptor Patched (hPtc)
could be functionally expressed in Drosophila Schneider 2 cells [10].
We show in the present paper that hPtc can be expressed at the
membrane fraction of the yeast Saccharomyces cerevisiae and puriﬁed
in a native and stable conformation. To demonstrate that, we
expressed and puriﬁed the fully active amino-terminal signalling
domain of the secreted protein Shh (N-Shh) and used it to measure
the ability of hPtc to interact with its ligand N-Shh both in the yeast
membrane fraction and after puriﬁcation in solution with different
surfactants.
2. Materials and methods
2.1. Construction of expression vectors
For S. cerevisiae, we used the YEpGAL vector containing the GAL1-
10 promotor and the YEpPMA vector containing the plasma
membrane proton ATPase (PMA) promotor, generously given by Al-
Shawi et al. [11]. The Multitag Afﬁnity Puriﬁcation (MAP) sequence
encoding (i) a factor Xa, a TEV and thrombin cleavage sites to
eliminate the MAP sequence; (ii) a calmodulin binding domain (CBD),
a streptavidin tag and an hexahistidine tag for afﬁnity chromato-
graphy; and (iii) an hemagglutinin peptide (HA) for anti-HAWestern
blot analysis [12], was inserted into the BamHI and XhoI restriction
sites of the YEpGAL or YEpPMA polylinker, to yield YEpGAL-MAP,
YEpPMA-MAP vectors. PCR with the Proofstart polymerase (Qiagen)
was carried out on the hPtc cDNA to introduce at the 5′ end two
restriction sites (SpeI) and a sequence of six adenosines, and at the 3′
end, a NheI restriction site, using the following primers: 5′-ACT AGT
TCT AGA GAG CTC CCG CGG AAA AAA TCG GCT GGT AAC GCC GCC GAG
CCC, and 5′-GGT ACC TCT AGA TCA GCT AGC GTT GGA GCT TCC CCG
GGG CCT CTC. The PCR product was subcloned in the pCR™ 2.1
plasmid (Invitrogen) and sequenced. hPtc cDNAwas then digested by
SpeI and NheI and subcloned inMAP NheI sites, giving, YEpPMA-hPtc-
MAP and YEpGAL-hPtc- MAP (Fig. 1).
2.2. Yeast strains, media, culture and transformation
S. cerevisiae strain K699 (Mata, ura3, and leu 2–3) generously given
by R. Arkowitz was transformed with YEpGAL-hPtc-MAP, YEpPMA-
hPtc-MAP, YEpPMA-MAP or YEpGAL-MAP by the lithium acetate
procedure [13] and spread out on plates containing minimal medium
and an amino acidmixture lacking leucine. Clones were precultured at
30 °C until 3 OD600 on minimal medium (MM) (0.67% yeast nitrogen
base without amino acids, 0.3 mM adenine, 0.5 mM uracil, 0.3 mM
tyrosine and an amino acid mixture lacking leucine) supplemented
with 2% D-glucose for YEpPMAvectors orwith 2% galactose for YEpGAL
vectors. This preculture was then diluted to 0.1 OD600 in complete
medium (yeast extract, bactopeptone, adenine), 2% D-glucose (or 2%
galactose for YEpGAL vectors) and grown at 20 °C under 200 rpm
shaking until 7 OD600 and centrifuged for 10 min at 2000 g and 4 °C.Fig. 1.MAP sequence fused at hPtc C-terminal end. Map sequence is composed of 165 amino a
tag and a hexahistidine tag), the hemagglutin A epitope , and cleavage sites for factor Xa, T2.3. Membrane preparation
All steps were performed at 4 °C. Yeast cells were washed in cold
water, resuspended in 50 mM Tris–HCl (pH 7.4), 300 mM NaCl,
2.5 mM EDTA, 1 mM PMSF and 4 mM benzamidine, and broken by
vortexing 15 min with glass beads (425–600 μm, Sigma). Unbroken
yeasts and beads were removed by centrifugation for 5 min at 2000 g.
Membranes were collected by centrifugation of the supernatant for
1 h at 100,000 g. The pellet was washed twice in the same buffer
without EDTA and resuspended ﬁnally at 5 mg/mL in a solubilization
buffer containing 50 mM Tris–HCl (pH 7.4), 300 mM NaCl, 10%
glycerol, 1 mM PMSF and 4 mM benzamidine.
2.4. hPtc solubilization
Membrane preparations from S. cerevisiae expressing hPtc
(5 mg/mL) were solubilized with different detergents in the solubili-
zation buffer at 4 °C during 20 min under gentle agitation and then
centrifuged at 100,000 g for 1 h to discard the insoluble fraction. The
detergents testedwere the non-ionic detergentsDDM(n-dodecyl-β-D-
maltoside, CMC=0.15 mM), Nonidet NP40 (a nonyl phenoxypo-
lyethoxylethanol, CMC=0.059 mM) and Triton X-100 (CMC=0.2–
0.9 mM), the zwitterionic detergent CHAPS (3-[(3-Cholamidopropyl)
dimethylammonio]-1-propanesulfonate, CMC=6mM), and the anio-
nic detergent SDS (Sodium dodecyl sulfate, CMC=7–10 mM) (CMC
values obtained from Sigma Aldrich catalogue). Samples were run on
SDS-PAGE for western blotting, and revealed with the anti-HA
antibody to compare the solubilization conditions.
2.5. hPtc puriﬁcation
The membrane protein fraction (5 mg/mL) was solubilized in
solubilization buffer, in the presence of 1% (20 mM) of DDM
(Calbiochem), 20 min at 4 °C under gentle agitation, and then
centrifuged at 100,000 g for 1 h to discard the insoluble fraction. All
puriﬁcation steps were carried out at 4 °C. One-half of the
supernatant was supplemented with 2 mM CaCl2, the other half
with 10 mM imidazole, and batch loaded during 3 h onto,
respectively, 1 volume of calmodulin Sepharose (Amersham), or 1
volume of Ni-NTA agarose (Qiagen) pre-equilibrated. The resins were
centrifuged for 1 min at 400 g, resuspended in 10 volumes of washing
buffer (solubilization buffer plus 2 mM DDM, and 2 mM CaCl2 or
10 mM imidazole) and centrifuged. This washing step was repeated
three times. The resins were then incubated for 10 minwith 1 volume
of elution buffer (solubilization buffer plus 2 mM DDM and 4 mM
EGTA for calmodulin sepharose, 50–500 mM imidazole for Ni-NTA
agarose). The eluates were collected after centrifugation for 1 min at
400 g. The elution step was also repeated three times. To test the
stability of hPtc in ﬂuorinated surfactants, DDM was exchanged with
C6F13C2H4-S-poly-Tris-(hydroxymethyl)aminomethane (F6-TAC)
(CMC=0.3 mM), or a slightly longer version, C8F17C2H4-S-poly-Tris-
(hydroxymethyl)aminomethane (F8-TAC) (CMC=0.03 mM) [14,15]
on calmodulin column during the washing step by replacing DDMcids: three afﬁnity puriﬁcation tags (a calmodulin binding domain (CBD), a streptavidin
EV and thrombin.
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from the column with elution buffer containing 2 mM F6-TAC or F8-
TAC in place of DDM.
2.6. Protein quantiﬁcation
The proteins were quantiﬁed using the Bio-Rad protein assay.
2.7. Gel electrophoresis and western blotting
Protein samples were separated on 8% SDS-PAGE and transferred
to nitrocellulose membranes (Amersham) using standard techniques.
Membranes were ﬁrst blocked 1 h at room temperature in blocking
buffer (20 mM Tris–HCl (pH 7.5); 450 mM NaCl; 0.1% Tween-20, 5%
non-fat milk), probed overnight at 4 °C with monoclonal mouse anti-
HA (laboratory made, dilution 1:20), polyclonal rabbit anti-Shh
(laboratory made, dilution 1:1000) or polyclonal rabbit anti-Ptc
(laboratory made, dilution 1:1000) antibodies, and then washed
thrice in the blocking buffer. Secondary polyclonal goat anti-mouse
immunoglobulins (dilution 1:5000) or polyclonal anti-rabbit immu-
noglobulins (dilution 1:2000) coupled to horseradish peroxidase
(Dako) were then applied for 2 h at 4 °C. Revelation was carried out
using ECL kit (AmershamBiosciences), a CCD camera and the Las 3000
system® (Fuji).
2.8. Expression of N-Shh protein
The active amino-terminal part of the murine Shh protein (N-Shh
corresponding to amino acids 25 to 198) was cloned into the XhoI site
of the mammalian pABWN expression vector (pHH015 plasmid). The
expression is under control of CMV enhancer/chicken β-actin
promoter. This construct was transfected into mouse ﬁbroblast L-
cells (LTK-P2 cells). Cells stably expressing the construct were selected
by addition of 800 μg/mL G418 (Gibco/BRL) in the culture medium
(Dulbecco's modiﬁed Eagle's medium supplemented with 10% fetal
bovine serum, 1% Na-pyruvate, 2 mM L-glutamine, 100 U/mL peni-
cillin and 100 μg/mL streptomycin (all from Biowhittaker)). The
expression of N-Shh protein was assayed in the culture medium using
western blot experiment. The cell population expressing the higher
level of N-Shh was adapted for growth in suspension by sequential
dilution in different serum free culture media. Best results have been
obtained by progressive adaptation to the ProCHO4-CDM medium
(Cambrex). Cells were then grown in suspension in this medium,
using either plastic Erlenmeyer ﬂasks in regulated Minitron (INFORS)
or CellSpin (Integra Biosciences) in regulated incubator (8% CO2
atmosphere in both cases).
2.9. Puriﬁcation of N-Shh− protein
Puriﬁcation was routinely started from 5 L conditioned culture
medium. The pH of the conditioned medium was adjusted to 7.4 by
adding Tris–HCl buffer (50 mM ﬁnal concentration). DTT (0.5 mM)
and PMSF (0.5 mM) were also added at that step. The conditioned
medium was clariﬁed either by centrifugation at 42,000 g for 3 h at
4 °C or by ﬁltration using a Stericup 0.22 μm GP Express Plus
(Millipore). The conductivity of the clariﬁed fraction was adjusted to
14 mS by addition of NaCl before loading on 25 mL SP Sepharose Fast
Flow column (XK 26/20 column, both from GE HealthCare). The
column was equilibrated with buffer A (25 mM Tris, pH 7.4, 50 mM
NaCl and 0.5mMDTT). Elutionwas carried outwith a linear gradient of
buffer B (buffer A containing1MNaCl) to 600mMNaCl. Fractionswere
analyzed for N-Shh content by SDS-PAGE followed with Coomassie
blue staining (Thermo). The N-Shh protein was eluted at about
400 mM NaCl. The protein was diluted 5 times in 25 mM Tris–HCl, pH
7.4 and 0.5 mM DTT, then further puriﬁed and concentrated on a 5 mL
Hitrap SP column (GE HealthCare) using the buffers described for theﬁrst chromatography. Elution was performed by applying a gradient
to 100% buffer B (i.e. 1 M NaCl) in 5 column volumes. The fractions
concentrated in N-Shh protein were pooled (puriﬁed N-Shh protein
concentrations ranging from300 to 600 μg/mL) then stored at−80 °C
until use.
2.10. Alkaline phosphatase (ALP) activity
C3H10T1/2 cells were seeded at 6000 cells/well in 96-well plates
containing alpha-MEM supplemented with 10% fetal bovine serum, 1%
Na-pyruvate, 2 mM L-glutamine, 100 U/mL penicillin and 100 μg/mL
streptomycin (all from Biowhittaker). The day after, the medium was
changed and FBS concentration decreased to 2%. At the same time
200ng/mLBMP2was addedwithpuriﬁedN-Shhprotein in thepresence
or absence of anti-Shhantibody 5E1 (Developmental StudiesHybridoma
Bank). The culture was continued for 48 h then cells were lysed using
75 μL lysis buffer (MgCl2 0.02%, NP40 0.2%) for 1 h at 37 °C. ALP activity
was read on 10 μL of cell extract by ﬂuorescence measurement (Ex:
435 nm–Em: 555 nm) after addition of 100 μL substrate (AttoPhos® AP
Fluorescent Substrate System Promega). The activity was standardized
with the total protein amount evaluated by BCA (Pierce).
2.11. Gli responsive element activity
GliC53-19 is a stable clone of C3H10T1/2 cells transfected with
reporter construct 5xGli responsive elements (RE) cloned in 5′ of a
minimal collagenase promoter, followed by luciferase coding gene.
GliC53-19 cells were seeded at 15,000 cells per well in 96-well plates
and allowed to grow overnight at 37 °C and 5% CO2 in alpha-MEM
supplementedwith 10% FBS,1%Na-pyruvate, 2mM L-glutamine,100 U/
mLpenicillin and 100 μg/mL streptomycin. The following day, cellswere
supplemented with N-Shh at different concentrations and allowed to
grow for 48 h. Cells were then lysed in 75 μL of 1× passive lysis buffer
(Promega) and luciferase activity was measured in the cell lysate by
luminescent assay following the manufacturer's procedure (Promega).
2.12. N-Shh western blotting
Samples were separated either on 10–20% Tris-Glycine or 4–12%
NuPAGE Bis-Tris gel following the manufacturer's procedure (Invitro-
gen). Proteins were then transferred for 16 h at 45 mA on
nitrocellulose membrane (Invitrogen). MagicMark XP Western Pro-
tein Standards (Invitrogen) were used as molecular weight markers.
Membranes were incubated for 60 min in saturation buffer (PBS
containing 0.5% Tween-20 (Fluka) and 5% skim milk) at room
temperature, and then incubated with a polyclonal rabbit anti-Shh
antibody (N-19 Santa Cruz Biotechnology, dilution 1:500) in the same
buffer for 1 h. After 3 washes for 15 min in PBS, 0.2% Tween 20, 0.35 M
NaCl, membranes were incubated with a Horseradish peroxidase
coupled polyclonal anti-rabbit immunoglobulin (Sigma, dilution
1:8000 in the saturation buffer) for 1 h. After 3 washes for 15 min
in PBS, 0.2% Tween 20, 0.35 M NaCl, blots were revealed using ECL
(Amersham) and Molecular Imager FX (Bio-Rad).
2.13. N-Shh /hPtc binding measurements
2.13.1. Using immunodectection
100 μg of S. cerevisiae membranes expressing hPtc diluted in PBS
were incubated with different concentrations of N-Shh for 1 h at 25 °C
under gentle shaking. The membranes were centrifuged for 1 h at
20,000 g at 4 °C. The pellets were then washed twice in 100 μL of PBS
and ﬁnally resuspended in 60 μL of PBS. 30 μL of these samples were
run on SDS-PAGE for western blotting together with increasing
concentrations of free N-Shh. The western blots were treated with
laboratory made polyclonal rabbit anti-Shh antibodies (dilution
1:1000 [16]). The N-Shh signal intensities on western blots were
Fig. 2. hPtc expression in S. cerevisiae membranes. (A) Western blot with 40 μg of a
membrane protein preparation from hPtc-expressing S. cerevisiae blotted with anti-HA
(1:20) (lane 1) or laboratory made anti-Ptc (1:1000) (lane 2) antibody. (B) Effect of
temperature and glycerol on the expression of hPtc at S. cerevisiae membrane fraction.
The western blot was probed with an anti-HA antibody. The control lane is loaded with
40 μg of a membrane protein preparation of wild-type S. cerevisiae grown at 20 °C
without glycerol. In the other lanes, 40 μg of membrane preparation from hPtc-
expressing S. cerevisiae were loaded. Yeasts were grown in the indicated conditions.
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the free N-Shh signals were used to make an N-Shh standard curve.
The intensities of the N-Shh signals associated to hPtc-containing
membrane samples were reported on this standard curve to estimate
the quantities of N-Shh speciﬁcally bound to hPtc in the membrane
fractions. This experiment has been repeated with membrane
preparations from three different hPtc-expressing yeast cultures.
2.13.2. Using Surface Plasmon Resonance (SPR) experiments
SPR experiments were performed on a Biacore 3000 (Biacore/GE
Healthcare, UMR IBSV, INRA Sophia Antipolis) with CM5 sensor chip
fromBiacore/GEHealthcare. 50 μg/mL of puriﬁedN-Shhwas prepared
in 10 mM Na-acetate pH5 and injected over the NHS/EDC− activated
ﬂow-cell (Fc) 2 of the Biacore CM5 sensor chip as described in the
Biacore manual to achieve an immobilization level of 5000 RU. Fc1
served as an ‘uncoated’ reference ﬂow-cell.
With membrane preparations, experiments were carried out at
20 °C. 40 μL of membrane preparation from hPtc-expressing yeast or
from yeast that do not express hPtc, diluted in HBS-N running buffer
(GE Healthcare) at 100 μg/mLwere injected over both Fc1 and Fc2 at a
ﬂow rate of 10 μL/min, and the difference between sensorgrams
recorded on Fc2 and Fc1 was reported. 10 μL of 4 M NaCl was injected
to regenerate the surface at 10 μL/min. Membranes from hPtc-
expressing yeast were mixed with puriﬁed N-Shh at four concentra-
tions from 0.5 to 20 nM, and the resulting solutions were injected over
reference (Fc1) and N-Shh (Fc2) surfaces.
With puriﬁed samples, experiments were carried out at 10 °C. 40 μL
of hPtc puriﬁed in DDM, F6-TAC or F8-TAC were injected over both Fc1
(reference) and Fc2 (coupled to N-Shh) of the CM5 sensor chip at
10 μL/min. Speciﬁc running buffer is used for each sample:
solubilization buffer plus 2 mM DDM, 2 mM C6F-TAC or 2 mM C8F-
TAC. The difference between sensorgrams recorded on Fc2 and Fc1 is
reported.10 μL of 4MNaCl was injected at 10 μL/min to regenerate the
surface. For inhibition assay hPtc puriﬁed in DDM, F6-TAC or F8-TAC
was incubated with free puriﬁed N-Shh at concentrations from 0.5 to
20 nM and injected over reference (Fc1) and N-Shh (Fc2) surfaces.
3. Results
3.1. hPtc is expressed in S. cerevisiae membranes
After modiﬁcation of the sequence by PCR to introduce restriction
sites and a sequence of six adenosines just upstream of the ATG
initiation codon in order to optimize the initiation of translation and
the protein expression [17], the hPtc cDNA was subcloned in the
expression vectors at the 5′-end of the MAP sequence. We therefore
expected to express hPtc with the MAP sequence at its C-terminal
extremity at a theoretical molecular weight of 180 kDa, allowing
detection of hPtc bywestern blot using antibodies directed against the
hemagglutinin tag, and puriﬁcation of hPtc using three afﬁnity resins
(calmodulin, streptavidin, and Ni-NTA), as already described for the
other receptor of the Hh pathway hSmo [12] (Fig. 1). S. cerevisiae was
then transformed with YEpGAL-hPtc-MAP and YEpPMA-hPtc-MAP
plasmids, allowing an inducible expression of hPtc by galactose or a
constitutive expression of hPtc respectively. Clones that integrated
one of the plasmids were able to grow on plates containing minimum
medium without leucine and were screened for expression of hPtc in
the membrane fraction by western blotting using antibodies directed
against the HA peptide present in the MAP sequence or against hPtc
(Fig. 2A). The same speciﬁc signal corresponding to hPtc-MAP is
observed around 180 kDa onwestern blots using both antibodies. The
intensities of this signal in different clones and culture conditions
were compared. We ﬁrst observed that the expression of hPtc was
comparable using both plasmids (data not shown). Therefore, all
further experiments were performed with the S. cerevisiae YEpPMA-
hPtc-MAP strain. Then, the best expressing clone was grown at 30 °Cor 20 °C, with or without 10% glycerol which as been shown to
increase human P-glycoprotein expression [11]. Fig. 2B shows that the
signal corresponding to hPtc-MAP is strongly increased when yeasts
are grown at 20 °C. The presence of glycerol does not increase the
intensity of the signal, meaning that its addition is not relevant for a
better expression of our protein. At 20 °C, the expression in the
membrane protein fraction reached a maximum at 7 OD600 nm over
which, at 9 OD600 nm for instance, it decreases.
3.2. hPtc can be puriﬁed using the MAP strategy
The best hPtc-expressing clone of S. cerevisiae was grown in the
best conditions established, at 20 °C until the OD600 nmwas 7 and then
the membrane fraction was prepared. In order to purify hPtc, the
membrane fractionwas solubilizedwith different detergents (Fig. 3A).
hPtc solubilization was equally efﬁcient in DDM, NP40 or Triton X100,
but was more efﬁcient in DDM than in CHAPS. Since DDM is one of the
most efﬁcient detergents for hSmo solubilization [12] and one of the
most frequently used non-ionic detergents for puriﬁcation and
crystallization of membrane proteins, it was chosen for hPtc puriﬁca-
tion. Therefore all puriﬁcation steps have been performed in the
presence of DDM. Different times of solubilization (from 20 min to
180 min) and concentrations of detergent (from 2 to 20 mM) were
tested. The best solubilization of hPtc was obtained after 20min at 4 °C
in 20 mM DDM. Same amounts of solubilized hPtc have been
incubated in batches with Ni-NTA and calmodulin resins in appro-
priate buffers and a western blot analysis was used to ascertain
binding to the resins (Fig. 3B). Half of the solubilized fraction was
loaded onto the Ni-NTA resin in the presence of 10 mM imidazole and
the resinwaswashed in the same buffer. Thenwe applied an imidazole
gradient from 50 mM to 300 mM (Fig. 3B, lanes 2–6). No hPtc was
detected in the ﬂow through (lane 1) and hPtc was eluted with 100 or
150 mM imidazole as conﬁrmed by the strong signal obtained in lanes
3 and 4 respectively. The other part of the solubilized fraction was
loaded on calmodulin resin with 2 mM CaCl2. After incubation, we
noticed that a certain amount is lost in the ﬂow through (lane 7). The
resin was then washed in the same buffer and hPtc was eluted three
times with 4 mM of EGTA (lanes 8–10). A band at 180 kDa
corresponding to the predicted size of hPtc appears strongly in the
ﬁrst elution (lane 8) and a weaker signal is observed in later elutions
(lanes 9 and 10). Puriﬁcation on Ni-NTA is only partial and hPtc
Fig. 3. Solubilization and puriﬁcation of hPtc expressed in S. cerevisiae. (A) A membrane
preparation from S. cerevisiae expressing hPtc (5 mg/mL) was solubilized with either
1% NP40 (lane 1), a mixture of 2% DDM and 1% CHAPS (lane 2), 2% CHAPS (lane 3), 1%
CHAPS (lane 4), 2% DDM (lane 5), 3% DDM (lane 6), 2% Triton×100 (lane 7) or 1% SDS
(lane 8). Samples were run on SDS-PAGE, transferred to a western blot and probed with
the anti-HA antibody. (B) Puriﬁcation of hPtc on Ni-NTA and calmodulin resins: the
grey triangle corresponds to the elution in 5 steps from 50 to 250 mM imidazole from
the Ni-NTA column (lanes 2–6), the grey rectangle corresponds to the elution with
4 mM EGTA from the calmodulin column (lanes 8–9), the ﬂow through of each resin
was loaded (black squares, lanes 1 and 7). Samples were run on SDS-PAGE, transferred
to a western blot and probed with the anti-HA antibody.
Fig. 4. N-Shh puriﬁcation and activity. (A) Purity analysis. N-Shh was expressed in
mouse ﬁbroblast L-cells and puriﬁed as described. Samples were run on 4–12% NuPage
Bis-Tris gels in MES buffer and stained with Coomassie blue. Lane 1: 2.5 μL SeeBlue
molecular weight markers (Invitrogen); lane 2 to 4: batch 1207-056P (10, 5 and 2.5 μL
respectively); lanes 5–6: BSA (500 and 250 ng respectively); lanes 7–8 : batch 28846-
159P, 10 and 5 μL respectively. N-Shh is indicated by an arrow. (B) Induction of the Gli
transduction pathway. 3 Different puriﬁed N-Shh batches were tested for their ability to
induce Gli responsive element in GliC53-19 cells. (●): 1207-046P; (▴): 28846-159P;
(■): 1207-056P. (C) Induction of alkaline phosphatase (ALP) activity is reversed by an
anti-Shh 5E1 antibody. Three different puriﬁed N-Shh batches (28846-159P, 1207-046P
and 1207-056P) were tested for their ability to synergize with BMP2 in ALP activity
induction in C3H10T1/2 cells. All samples contain 200 ng/mL BMP2. Control: treatment
without N-Shh. Incubation without or with 5E1 antibody at 10 μg/mL (dark and grey
boxes respectively).
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of hPtc is higher after calmodulin column than after Ni-NTA, however,
puriﬁcation on calmodulin resin allows to recover only 1% of the
fraction of hPtc initially present in the membrane preparation. Both
resins, Ni-NTA and calmodulin, can be used to purify hPtc. However,
Ni-NTA seems to be more efﬁcient as a ﬁrst step of puriﬁcation.
3.3. Production of pure and active N-Shh
The active amino-terminal part of the murine Sonic Hedgehog
protein (N-Shh), corresponding to amino acids 25 to 198 (89% identity
with human N-Shh) was expressed under the control of the CMV
enhancer/chicken β-actin promoter. This construct was transfected
into mouse ﬁbroblast L-cells and stably expressing populations were
obtained after antibiotic selection. In order to facilitate further
production scale-up, the best expressing cells were adapted to growth
in suspension. Various serum free medium were tested and the best
results were obtained with ProCHO4-CDM. Using this medium, cells
were growing well (about one division/24 h) and the N-Shh
expression level was as good as previously measured for the parental
adherent cells, about 2 to 4 mg/L in conditioned medium.
A standard puriﬁcation procedure was then designed using 5 L of
conditioned medium as starting material. Clariﬁcation of this medium
was very efﬁcient using either centrifugation or ﬁltration, both
without loss of N-Shh. The ﬁrst ion exchange chromatographic step
allowed the recovery of about 95% of the N-Shh protein. The large
majority of contaminant proteins were eliminated by a column wash
containing 200 mM NaCl. The protein was eluted at about 450 mM
NaCl. Since the purity of the N-Shh protein obtained after this
puriﬁcation step was already good, a second ion exchange chromato-
graphic step using the same resin was performed to mainly
concentrate the protein. Purity analysis of the ﬁnal product usingCoomassie blue staining after SDS-PAGE showed that the protein was
more than 90% pure with an occasional minor contamination by a
protein of very high molecular mass (Fig. 4A).
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protein was very active at inducing the Gli transduction pathway.
Using a cell line stably transfected with the luciferase gene under the
control of 5 Gli responsive elements, we observed a clear correlation
between an increase in the amount of N-Shh added to the cells and an
increase in luciferase activity (Fig. 4B). The same results were
obtained with different N-Shh preparations. Moreover, these different
preparations of our N-Shh protein showed exactly the same speciﬁc
Alkaline Phosphatase (ALP) activity in C3H10T1/2 cells, an activity
which was clearly inhibited by co-incubation with the commercially
available inhibiting anti-Shh antibody 5E1 (Fig. 4C).
3.4. Human Ptc expressed in yeast interacts with puriﬁed Shh in
membrane preparations
In order to know if human Ptc is expressed in S. cerevisiae in a native
conformation, its ability to interact with puriﬁed N-Shhwasmeasured
using two different techniques, either immunodetection or SPR.
3.4.1. Using immunodetection
After incubation with different concentrations of pure N-Shh
followed by three washes, the membrane protein preparations from
three different hPtc-expressing yeast cultures present a signalFig. 5. hPtc expressed in the yeast interactswith puriﬁedN-Shh. (A) Immunodetectionmeasu
membrane preparation incubated with 15 nM of N-Shh. Samples were run on SDS-PAGE, tra
western blot is presented at the left of the ﬁgure. The intensities of the free N-Shh signals w
standard curve presented in the right part of the ﬁgure. The intensity of the N-Shh signal asso
the quantity of N-Shh bound to hPtc. (B) Surface Plasmon Resonance measurements. The sen
channel Fc2 (on which puriﬁed N-Shh was immobilized by amine coupling) and the referen
Sensorgram A: 100 μL of hPtc-containing membrane preparation (100 μg/mL) have been in
Sensorgrams B, C, D, and E: inhibition assay in solution: binding responses of hPtc-containin
injected both over Fc1 and Fc2 (B: 173 RU, C: 145 RU, D: 137 RU, E: 112 RU). Sensorgram F: 10
have been injected both over Fc1 and Fc2 producing a signal corresponding to non-speciﬁc bcorresponding to N-Shh on western blots treated with anti-Shh
antibodies (see Fig. 5A as an example). This observation indicates that
hPtc expressed in S. cerevisiae interacted with its ligand N-Shh. In
order to estimate the quantity of N-Shh bound to hPtc, the N-Shh
signal intensities associated with hPtc-containing membranes were
measured using Image J software and compared with an N-Shh
standard curve established with the signal intensities corresponding
to increasing concentrations of pure N-Shh in three independent
experiments (see Fig. 5A as an example). Knowing that N-Shh
interacts with Ptc in a 1:1 molar ratio [18], the N-Shh signal obtained
in the experiment presented in Fig. 5A allowed us to estimate that this
membrane preparation contains around 75 pmol of hPtc able to
interact with N-Shh per mg of membrane proteins. The two other
membrane preparations analyzed for N-Shh interaction presented
around 50 pmol of functional hPtc per mg of membrane proteins. For
each liter of yeast giving around 20 mg of membrane proteins, we
estimate that between 200 and 250 μg of functional hPtc are produced
per liter of S. cerevisiae.
3.4.2. Using SPR technology
The Biacore 3000 Surface Plasmon Resonance (SPR) biosensor
allows the direct real-time detection of binding without chemical
labelling [19]. One of the binding partners is immobilized on therements. Lanes 1 to 4: 0.003, 0.03, 0.09 and 0.3 μg of pureN-Shh. Lanes 5: hPtc-containing
nsferred onwestern blot and probed with laboratory made anti-Shh. The corresponding
ere estimated by densitometry using the Image J software, and used to draw the N-Shh
ciated with hPtc-containing membraneswas reported on this standard curve to estimate
sorgrams presented are the difference between signal recorded on the N-Shh-coupling
ce channel Fc1 (activated with amine coupling reagents) of a Biacore CM5 sensorchip.
jected both over Fc1 and Fc2 producing a speciﬁc signal of 240 resonance units (RU).
g membrane preparation (100 μg/mL) mixed with 0.5, 1, 5 and 20 nM of puriﬁed N-Shh
0 μL of control membrane preparation fromyeasts that do not express hPtc (100 μg/mL)
inding. Window: binding response against N-Shh concentration for IC50 determination.
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causes a change in the refractive index at the biosensor surface
which is transformed into a measurable signal by light-sensitive
detector and expressed as resonance units (RU) on the recorded
sensorgram. Puriﬁed N-Shh was immobilized by covalent coupling to
a Biacore CM5 sensor chip (channel Fc2) producing a signal of
5000 RU. A membrane preparation containing hPtc have been
injected on both the reference channel (Fc1) treated with coupling
reagents but without N-Shh and the measure channel (Fc2) coupled
to N-Shh. The difference between the sensorgrams recorded on Fc2
and Fc1 shows a signal increase of 240 RU on Fc2 (Fig. 5B,
sensorgram A). An inhibition assay in solution was then carried
out with puriﬁed N-Shh added at increasing concentrations to
solutions of membrane preparation containing hPtc before injection
on N-Shh coated sensor chip. The superposition of the sensorgrams
shows that the binding of hPtc-containing membranes decreases
with increasing concentration of added N-Shh (Fig. 5B, sensorgrams
B, C, D, and E). Therefore, N-Shh in solution bound to hPtc contained
in yeast membranes and inhibits binding of the latter to the N-Shh
surface. The sensorgram F recorded with membrane preparation
from yeasts that don't express hPtc reports the non-speciﬁc binding
on N-Shh. The binding signal obtained when hPtc-containing
membranes were incubated with 20 nM of free N-Shh is just with
the top of the non-speciﬁc one indicating that 20 nM of free N-Shh
inhibits almost completely hPtc binding to N-Shh coupled to the
sensor chip. Plotting the binding response against N-Shh concentra-
tion produced a binding curve from which the calculated IC50 is
between 0.5 and 1 nM.Fig. 6. hPtc puriﬁed in ﬂuorinated surfactants interacts with N-Shh. (A) hPtc puriﬁed in
DDM, F6-TAC or F8-TAC was injected over both the N-Shh-coupling channel Fc2 (on
which puriﬁed N-Shh was immobilized by amine coupling) and the reference channel
Fc1 (activated with amine coupling reagents) of the Biacore CM5 sensor chip. The
Biacore SPR responses reported in resonance units (RU) are the differences between
sensorgrams recorded on Fc2 and Fc1, and correspond to the speciﬁc binding of hPtc on
immobilized N-Shh. (B) Inhibition assay in solution: binding response of hPtc puriﬁed
in F8-TAC mixed with 0 (sensorgram A), 0.5 nM (sensorgram B), 1 nM (sensorgram C),
5 nM (sensorgram D), 10 nM (sensorgram E) and 20 nM (sensorgram F) of free N-Shh.
Window: binding response against free N-Shh concentration for IC50 determination.3.5. Fluorinated surfactants preserve human Ptc integrity in solution
1 day after puriﬁcation in DDM, hPtc was injected on both the
reference (Fc1) and the measure (Fc2) channels of the CM5/N-Shh
sensor chip. The difference between the sensorgrams recorded on Fc2
and Fc1 gave a signal of 244 RU indicating that a certain amount of
hPtc was able to interact with its ligand after puriﬁcation in DDM
(Fig. 6 A). The signal recorded was relatively stable in time (measures
realized until 1 month after puriﬁcation). Fluorinated surfactants
(FSs) have been shown to be less aggressive towards certain
membrane proteins than classical detergents [20–22]. FSs show the
same general structure as classical detergents, i.e. a hydrophilic head
group and a hydrophobic tail, but the latter, rather than being a
hydrogenated aliphatic chain, comprises ﬂuorine atoms [14,15].
Because FSs are poor solvents for lipids, membranes were solubilized
with DDM, and DDM was then exchanged on the calmodulin column
to F6-TAC or a slightly longer version, F8-TAC. The capacity of hPtc to
interact with its puriﬁed ligand N-Shh when puriﬁed in DDM, F6-TAC
and F8-TAC was measured on the CM5/N-Shh Biacore sensor chip.
1 day after puriﬁcation, hPtc puriﬁed in F6-TAC or F8-TAC bound to N-
Shh produced a signal of approximately 430 RU, suggesting that a
larger amount of hPtc was able to interact with N-Shh when puriﬁed
in FSs in comparison to DDM (Fig. 6A). The binding signals recorded
slightly decreased (10 to 40 % depending on puriﬁcations) 3 days
after puriﬁcation and stayed stable in time until 1 month after
puriﬁcation. An inhibition assay in solution was then carried out with
free puriﬁed N-Shh added at increasing concentrations to solutions of
hPtc puriﬁed in the ﬂuorinated surfactants before injection on N-Shh
coupled to the sensor chip. Fig. 6B shows that the binding of hPtc in
solution with F8-TAC decreases with increasing concentration of free
N-Shh added. Analysis of the results indicates that free N-Shh inhibits
binding of hPtc to N-Shh coupled on the sensor chip with an IC50
around 0.5 nM, comparable to the IC50 obtained with hPtc in
membrane preparations. These results suggest that ﬂuorinated
surfactants are efﬁcient for preserving hPtc integrity and stability in
solution.4. Discussion
In this study, the human receptor of themorphogen Shh (hPtc) has
been expressed in the yeast S. cerevisiae in fusion with a multitag
afﬁnity puriﬁcation sequence at its C-terminal end. Expression of hPtc
at the yeast membrane fraction was tested under several promoters,
clones and growth conditions. We observed that constitutive expres-
sion of hPtc had no effect on yeast growth and gave the same
expression levels as the inducible system. As observed for human Smo
expression in S. cerevisiae [12] and other integral membrane proteins,
decreasing growth temperature from 30 °C to 20 °C strongly increased
the expression level of hPtc. This is consistent with various other
studies suggesting that folding and stability of membrane proteins are
often favorably inﬂuenced by low temperatures [23]. As for hSmo, the
level of hPtc at the yeast membrane fraction decreased if cells reached
an OD600 nm over 7 and this is probably the result of translational or
post-translational events such as proteolysis or protein degradation
[24]. We concluded that constitutive expression from the promoter of
the plasma membrane ATPase, in rich medium at 20 °C at 7 OD600 nm
units were the best conditions for the expression of hPtc at S.
cerevisiae membrane fraction.
A way to evaluate the conformational state of hPtc expressed in S.
cerevisiae is to measure its ability to interact with its natural ligand N-
Shh. N-Shh derives from the Shh precursor through an autoprocessing
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the Shh protein active in signalling as a ligand for the receptor Ptc [18].
In order tomeasure the interaction between hPtc and its ligand, the N-
terminal part of murine Shh was expressed in ﬁbroblast L-cells and
puriﬁed. Our results show that puriﬁed recombinant N-Shh is fully
active and able to induce the Hh pathway in mouse pluripotent stem
cells. Experiments carried out on membrane preparations using two
different techniques, immunodetection and Surface Plasmon Reso-
nance, clearly demonstrate that human Ptc expressed in S. cerevisiae is
able to interact with puriﬁed N-Shh. Knowing that N-Shh interacts
with Ptc in a 1:1 molar ratio [18], we estimated from immunodetec-
tion experiments that our membrane preparations contain 50 to
75 pmol of hPtc per mg of membrane proteins, meaning that between
200 and 250 μg of functional hPtc are produced per liter of S.
cerevisiae. This is not a high expression level but should be sufﬁcient to
allow puriﬁcation of hPtc for biochemical and structural studies. Using
Biacore SPR technology, we observed that N-Shh in solution bound to
hPtc contained in membranes, therefore inhibiting the binding of hPtc
to the N-Shh-coupled surface. An IC50 value of 0.5 to 1 nM was
obtained, which is in close agreement with the KD value of 1.2 nM
reported using labelled recombinant human N-Shh on oocytes
injected with chick ptc mRNA [25]. This is also the same order of
magnitude of the concentration of N-Shh required for biological effect
in vivo [26], suggesting that hPtc is expressed in a native conformation
in S. cerevisiae.
After solubilization of hPtc from the membrane with the non-ionic
detergent DDM, we showed that hPtc could be puriﬁed using afﬁnity
tags present in the MAP sequence at its C-terminal end. However,
Biacore SPR experiments showed that only a fraction of hPtc puriﬁed
in this detergent was able to interact with its ligand N-Shh. Several
studies have reported that ﬂuorinated surfactants are less aggressive
towards certain membrane proteins than classical detergents [20–22].
Presumably because they do not compete effectivelywith the protein–
protein and protein–lipid interactions that stabilize the native fold of
membrane proteins, ﬂuorinated surfactants can keep membrane
proteins water-soluble under particularly mild conditions. In the
present study, we show using Biacore SPR technology that when DDM
is exchanged with ﬂuorinated surfactants during puriﬁcation, the
fraction of hPtc able to interact with its ligand N-Shh is higher than in
DDM, and stable in time after puriﬁcation. Moreover, the IC50
determined for N-Shh binding with hPtc in solution with the
ﬂuorinated surfactants is comparable to the IC50 determined with
hPtc in a membrane environment. This result suggests that the fraction
of hPtc able to interact with its ligand in solution with the ﬂuorinated
surfactants is in the same conformation than in the membrane. This is
the ﬁrst study reporting conditions in which the human receptor Ptc is
in a native and stable conformational state able to interact with its
natural ligand N-Shh in solution after puriﬁcation.
These results encourage us to work on the puriﬁcation procedure
scale-up to develop crystallization trials and structural characteriza-
tion of hPtc. Yeast is the simplest eukaryotic cell that performsmany of
the post-translational modiﬁcations seen in higher eukaryotic cells.
Moreover, it is easy to grow in large volumes in a short period of time
[27]. S. cerevisiae has been successfully used to functionally express
and purify various mammalian membrane proteins such as the
recombinant rabbit SERCA1a Ca2+-ATPase, allowing the determina-
tion of the ﬁrst structure of a mammalian membrane protein derived
from a heterologous expression system [28]. This structurewas shown
to be the same as the one obtained from native protein puriﬁed from
muscle [29]. This result demonstrates that a recombinant membrane
protein produced in a heterologous expression system can adopt the
same structure as the native one. Among ten atomic structures of
mammalian membrane proteins derived from heterologous expres-
sion solved since 2005, ﬁve were derived from proteins expressed in
yeast [28,30–33]. This is very encouraging, and although the process of
producing, purifying and crystallizing these integral membraneproteins is challenging, the relevance for pharmacological research
justiﬁes these efforts. Mutations that lead to constitutive Hh signalling
are found in Gorlin's syndrome, a familial cancer syndrome char-
acterized by neoplasms that include basal cell carcinomas and
medulloblastomas [34,35]. Inappropriate activation of the pathway
has been implicated in the pathogenesis of sporadic human cancers of
the skin, brain, lung, prostate, pancreas and gastrointestinal tract
[2,36]. The ﬁrst and often genetically damaged step in the Hh pathway
is the interaction between the two membrane receptors, Ptc and Smo.
Puriﬁcation of Ptc will allow biochemical and structural studies which
will shed light on the mechanism of the regulation of Smo activity by
Ptc, and thus provide new strategies for cancer treatment.
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